Results 61 to 70 of about 356,556 (259)

P1373: TACKLING IMMUNOLOGICAL FINDINGS AS SURROGATE MARKERS OF HISTOLOGICAL SEVERITY AND RESPONSE TO THERAPY IN ACUTE GASTROINTESTINAL GRAFT-VERSUS-HOST DISEASE

open access: yesHemaSphere, 2022
M. Sousa-Pimenta   +7 more
doaj   +1 more source

Frequency of BCR-ABL Fusion Transcript in Iranian Patients with Chronic Myeloid Leukemia

open access: yesInternational Journal of Hematology-Oncology and Stem Cell Research, 2005
Introduction: Reverse transcriptase-polymerase chain reaction (RT-PCR) assay is a useful tool for the detection of fusion transcript resulting from specific chromosomal translocation of the leukemia cells.
M Yaghmaie   +8 more
doaj  

A synthetic three-dimensional niche system facilitates generation of functional hematopoietic cells from human-induced pluripotent stem cells

open access: yesJournal of Hematology & Oncology, 2016
Background The efficient generation of hematopoietic stem cells (HSCs) from human-induced pluripotent stem cells (iPSCs) holds great promise in personalized transplantation therapies.
Yulin Xu   +18 more
doaj   +1 more source

Induction of hemopoiesis in rat embryonic bone transplanted into adult subcutaneous connective tissue [PDF]

open access: yes, 1978
Five pairs of immature, non-hemopoietic femur and tibia from 17-day-old gestating female rat fetuses, whose sex was determined by chromosomal analysis of liver cells, were transplanted into subcutaneous tissues of adult male rats. The original bones were
Hsueh, Chao Liang
core   +1 more source

Effect in supralethally irradiated rats of granulocyte colony- stimulating factor and lisofylline on hematopoietic reconstitution by syngeneic bone marrow or whole organ passenger leukocytes [PDF]

open access: yes, 1997
We have previously shown the existence of migratory hematopoietic stem cells in adult solid organs. This study demonstrates that granulocyte colony- stimulating factor (G-CSF) and lisofylline, a phosphatidic acid inhibitor that suppresses hematopoiesis ...
Abdul Rao   +23 more
core   +1 more source

HMGB1 knockdown increases MM cell vulnerability by regulating autophagy and DNA damage repair

open access: yesJournal of Experimental & Clinical Cancer Research, 2018
Background With the development of novel therapeutic agents, the survival of multiple myeloma (MM) patients has much improved. However, the disease is incurable due to drug resistance. Previous studies have found that high-mobility group box 1 (HMGB1) is
Xing Guo   +11 more
doaj   +1 more source

Endothelial and Complement Activation As Predictors of Survival in Adult Allogeneic Hematopoietic Cell Transplantation

open access: yesHemaSphere, 2021
Eleni Gavriilaki   +13 more
doaj   +1 more source

Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report

open access: yesBMC Cancer, 2019
Background Patients with relapsed/refractory acute myeloid leukemia after hematopoietic stem cell transplantation (HSCT) have a poor prognosis, with a 2-year survival rate of 14%. The optimal treatment for these patients remains unclear.
Mengqi Jin   +9 more
doaj   +1 more source

Experimental bone marrow transplantation [PDF]

open access: yes, 1968
This study formed part of a theses entitled “The Influence of extra-corporeal irradiation on Lympho- and Haemopoiesis” submitted by Dr. Maurice N. Cauchi to the University of London for the Ph.D. degree, 1967.
Cauchi, Maurice N.
core  

Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation [PDF]

open access: yes, 2017
BACKGROUND: Allogeneic hematopoietic cell transplantation (HCT) is a curative therapy for patients with acute myeloid leukemia (AML). However, post-HCT relapse and regimen-related toxicity remain significant barriers to long-term survival.
Al Mumma   +41 more
core   +1 more source

Home - About - Disclaimer - Privacy